Knowledge and Attitude towards Clinical Trials among General Population of Northern Saudi Arabia during COVID-19 Era: A Cross-Sectional Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Setting
2.2. Sample Size Estimation and Sampling Method
2.3. Inclusion and Exclusion Criteria
2.4. Data Collection
2.5. Calculation and Categorization of Knowledge and Attitude Score
2.6. Data Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- WHO. International Clinical Trials Registry Platform (ICTRP). Available online: https://www.who.int/clinical-trials-registry-platform (accessed on 15 January 2022).
- Hariton, E.; Locascio, J.J. Randomised controlled trials—The gold standard for effectiveness research: Study design: Randomised controlled trials. Bjog 2018, 125, 1716. [Google Scholar] [CrossRef] [Green Version]
- John, K.S.; McNeal, K.S. The Strength of Evidence Pyramid: One Approach for Characterizing the Strength of Evidence of Geoscience Education Research (GER) Community Claims. J. Geosci. Educ. 2017, 65, 363–372. [Google Scholar] [CrossRef]
- Pascual, M.A.; Fors, M.M.; Jiménez, G.; López, I.; Torres, A. Public health approach of clinical trials: Cuban’s experience of research translation into clinical practice. BMC Health Serv. Res. 2014, 14, P149. [Google Scholar] [CrossRef] [Green Version]
- Landray, M.J.; Bax, J.J.; Alliot, L.; Buyse, M.; Cohen, A.; Collins, R.; Hindricks, G.; James, S.K.; Lane, S.; Maggioni, A.P.; et al. Improving public health by improving clinical trial guidelines and their application. Eur. Heart J. 2017, 38, 1632–1637. [Google Scholar] [CrossRef] [Green Version]
- Unger, J.M.; Xiao, H. The COVID-19 pandemic and new clinical trial activations. Trials 2021, 22, 260. [Google Scholar] [CrossRef] [PubMed]
- Psotka, M.A.; Abraham, W.T.; Fiuzat, M.; Filippatos, G.; Lindenfeld, J.; Ahmad, T.; Bhatt, A.S.; Carson, P.E.; Cleland, J.G.F.; Felker, G.M.; et al. Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel. J. Am. Coll. Cardiol. 2020, 76, 2368–2378. [Google Scholar] [CrossRef]
- Huang, G.D.; Bull, J.; Johnston McKee, K.; Mahon, E.; Harper, B.; Roberts, J.N. Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation Initiative. Contemp. Clin. Trials 2018, 66, 74–79. [Google Scholar] [CrossRef] [Green Version]
- Ali, S.; Alghamdi, M.A.; Alzhrani, J.A.; De Vol, E.B. Magnitude and characteristics of clinical trials in the Kingdom of Saudi Arabia: A cross-sectional analysis. Contemp. Clin. Trials Commun. 2017, 7, 126–129. [Google Scholar] [CrossRef]
- US-FDA. Drug Trials Snapshots Summary Report Five-Year Summary and Analysis of Clinical Trial Participation and Demographics Contents. Available online: https://www.fda.gov/media/143592/download (accessed on 12 October 2022).
- ClincalTrials.Gov. Trends, Charts, and Maps of Clinical Trials Participation. Available online: https://clinicaltrials.gov/ct2/resources/trends (accessed on 15 February 2021).
- Nair, S.C.; Ibrahim, H.; Celentano, D.D. Clinical trials in the Middle East and North Africa (MENA) Region: Grandstanding or grandeur? Contemp. Clin. Trials 2013, 36, 704–710. [Google Scholar] [CrossRef] [PubMed]
- Thoma, A.; Farrokhyar, F.; McKnight, L.; Bhandari, M. Practical tips for surgical research: How to optimize patient recruitment. Can. J. Surg. 2010, 53, 205–210. [Google Scholar] [PubMed]
- Singh, A.G.; Chaturvedi, P. Clinical trials during COVID-19. Head Neck 2020, 42, 1516–1518. [Google Scholar] [CrossRef]
- Bassi, A.; Arfin, S.; Joshi, R.; Bathla, N.; Hammond, N.E.; Rajbhandari, D.; Tirupakuzhi Vijayaraghavan, B.K.; Venkatesh, B.; Jha, V. Challenges in operationalising clinical trials in India during the COVID-19 pandemic. Lancet Glob. Health 2022, 10, e317–e319. [Google Scholar] [CrossRef] [PubMed]
- Al-Lawati, H.; Al-Baimani, K.; Al-Zadjali, M.; Al-Obaidani, N.; Al-Kiyumi, Z.; Al-Khabori, M.K. Knowledge and Attitudes Towards Clinical Trial Participation in Oman: A cross-sectional study. Sultan. Qaboos. Univ. Med. J. 2018, 18, e54–e60. [Google Scholar] [CrossRef] [Green Version]
- Al-Rawashdeh, N.; Damsees, R.; Al-Jeraisy, M.; Al Qasim, E.; Deeb, A.M. Knowledge of and attitudes toward clinical trials in Saudi Arabia: A cross-sectional study. BMJ Open 2019, 9, e031305. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Patel, E.U.; Zhu, X.; Quinn, T.C.; Tobian, A.A.R. Public Knowledge and Attitudes Toward Clinical Trials in the COVID-19 Era. Am. J. Prev. Med. 2022, 62, 469–471. [Google Scholar] [CrossRef] [PubMed]
- Al-Tannir, M.A.; Katan, H.M.; Al-Badr, A.H.; Al-Tannir, M.M.; Abu-Shaheen, A.K. Knowledge, attitudes, practices and perceptions of clinicians towards conducting clinical trials in an Academic Tertiary Care Center. Saudi Med. J. 2018, 39, 191–196. [Google Scholar] [CrossRef] [PubMed]
- Altaf, A.; Bokhari, R.; Enani, G.; Judeeba, S.; Hemdi, A.; Maghrabi, A.; Tashkandi, H.; Aljiffry, M. Patients’ attitudes and knowledge toward clinical trial participation. Saudi Surg. J. 2019, 7, 69–74. [Google Scholar] [CrossRef]
- Feleke, B.T.; Wale, M.Z.; Yirsaw, M.T. Knowledge, attitude and preventive practice towards COVID-19 and associated factors among outpatient service visitors at Debre Markos compressive specialized hospital, north-west Ethiopia, 2020. PLoS ONE 2021, 16, e0251708. [Google Scholar] [CrossRef] [PubMed]
- Yadav, S.; Todd, A.; Patel, K.; Tabriz, A.A.; Nguyen, O.; Turner, K.; Hong, Y.-R. Public knowledge and information sources for clinical trials among adults in the USA: Evidence from a Health Information National Trends Survey in 2020. Clin. Med. 2022, 22, 416–422. [Google Scholar] [CrossRef] [PubMed]
- Alqahtani, A.M.; Almazrou, S.H.; Alalweet, R.M.; Almalki, Z.S.; Alqahtani, B.F.; AlGhamdi, S. Impact of COVID-19 on Public Knowledge and Attitudes Toward Participating in Clinical Trials in Saudi Arabia: A Cross-Sectional Study. Int. J. Gen. Med. 2021, 14, 3405–3413. [Google Scholar] [CrossRef]
- Elshammaa, K.; Hamza, N.; Elkholy, E.; Mahrous, A.; Elnaem, M.; Elrggal, M. Knowledge, attitude, and perception of public about participation in COVID-19 clinical trials: A study from Egypt and Saudi Arabia. Saudi Pharm. J. 2022, 30, 283–290. [Google Scholar] [CrossRef]
- Mosconi, P.; Roberto, A.; Cerana, N.; Colombo, N.; Didier, F.; D’Incalci, M.; Lorusso, D.; Peccatori, F.A.; Artioli, G.; Cavanna, L.; et al. Knowledge and attitudes towards clinical trials among women with ovarian cancer: Results of the ACTO study. J. Ovarian Res. 2022, 15, 45. [Google Scholar] [CrossRef] [PubMed]
- Awwad, O.; Maaiah, S.; Almomani, B.A. Clinical trials: Predictors of knowledge and attitudes towards participation. Int. J. Clin. Pract. 2021, 75, e13687. [Google Scholar] [CrossRef] [PubMed]
- Ahram, M.; Farkouh, A.; Haddad, M.; Kalaji, Z.; Yanis, A. Knowledge of, attitudes to and participation in clinical trials in Jordan: A population-based survey. East Mediterr. Health J. 2020, 26, 539–546. [Google Scholar] [CrossRef]
- Andrade, G. The ethics of positive thinking in healthcare. J. Med. Ethics Hist. Med. 2019, 12, 18. [Google Scholar] [CrossRef]
- Eagleson, C.; Hayes, S.; Mathews, A.; Perman, G.; Hirsch, C.R. The power of positive thinking: Pathological worry is reduced by thought replacement in Generalized Anxiety Disorder. Behav. Res. Ther. 2016, 78, 13–18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Staniszewska, A.; Lubiejewska, A.; Czerw, A.; Dąbrowska-Bender, M.; Duda-Zalewska, A.; Olejniczak, D.; Juszczyk, G.; Bujalska-Zadrożny, M. Awareness and attitudes towards clinical trials among Polish oncological patients who had never participated in a clinical trial. Adv. Clin. Exp. Med. 2018, 27, 525–529. [Google Scholar] [CrossRef] [PubMed]
- Anderson, A.; Borfitz, D.; Getz, K. Global Public Attitudes about Clinical Research and Patient Experiences with Clinical Trials. JAMA Netw. Open. 2018, 1, e182969. [Google Scholar] [CrossRef] [Green Version]
- Taafaki, M.R.; Brown, A.C.; Cassel, K.D.; Chen, J.J.; Lim, E.; Paulino, Y.C. Knowledge and Attitudes of Guam Residents towards Cancer Clinical Trial Participation. Int. J. Environ. Res. Public Health 2022, 19, 15917. [Google Scholar] [CrossRef]
- NIH. Why Should I Participate in a Clinical Trial? Available online: https://www.nih.gov/health-information/nih-clinical-research-trials-you/why-should-i-participate-clinical-trial#:~:text=Healthy%20volunteers%20say%20they%20participate,from%20the%20clinical%20trial%20staff (accessed on 19 December 2022).
- Ranjan, R.; Agarwal, N.B.; Kapur, P.; Marwah, A.; Parveen, R. Factors Influencing Participation of Healthy Volunteers in Clinical Trials: Findings from a Cross-Sectional Study in Delhi, North India. Patient Prefer. Adherence 2019, 13, 2007–2015. [Google Scholar] [CrossRef] [Green Version]
Variable | Number (n) | Percentage (%) | |
---|---|---|---|
Age group (years) | Less than 30 years 30 to 45 years Above 45 years | 190 165 125 | 39.6 34.4 26.0 |
Gender | Male Female | 305 175 | 63.5 36.5 |
Marital status | Married Unmarried * | 361 119 | 75.2 24.8 |
Employment status | Public sector job Private job/self-employed/business Unemployed Retired | 195 111 102 72 | 40.6 23.1 21.3 15.0 |
Education level | Up to high school University level | 179 301 | 37.3 62.7 |
Income ** | Less than SAR 5000 SAR 5000 to 10,000 More than SAR 10,000 | 161 172 147 | 33.5 35.8 30.6 |
Presence of any chronic diseases | Yes No | 124 356 | 25.8 74.2 |
Previous participation in health research | Yes No | 73 407 | 15.2 84.8 |
Item | Number (n) | Percentage (%) | |
---|---|---|---|
Have you ever heard about clinical trials (CTs)? | Yes No/not sure | 170 310 | 35.4 64.6 |
Definition of a CT | Correct answer Wrong answer | 192 288 | 40.0 60.0 |
Have you heard of an ethics review committee for a CT? | Yes No | 93 387 | 19.4 80.6 |
Have you heard about the Saudi FDA? | Yes No | 270 210 | 56.3 43.7 |
Does the general authority of food and drug administration have any role in CT’s policy? | Yes No | 376 104 | 78.3 21.7 |
Are there any ethical guidelines to regulate CTs? | Yes No | 398 82 | 82.9 17.1 |
Is there a direct benefit to the participants in CTs? | Correct answer Wrong answer | 98 382 | 20.4 79.6 |
Is there a direct benefit to the Saudi community due to the people participating in CTs? | Yes No | 415 65 | 86.5 13.5 |
When can the research team start a CT? | Correct answer Wrong answer | 235 245 | 49.0 51.0 |
Can the research team initiate the CT without the consent of the participants? | Yes No | 436 44 | 90.8 9.2 |
Are the participants free to withdraw from the CT at any time? | Yes No | 312 168 | 65.0 35.0 |
Patients’ confidential information (such as name) can be disclosed in the published article? | Yes No | 183 297 | 38.1 61.9 |
Total knowledge score (mean ± SD) | 7.10 ± 2.03 |
Item | Number (n) | Percentage % | |
---|---|---|---|
Do you agree to test a new experimental non-approved drug on patients? | Yes No/not sure | 116 364 | 24.2 75.8 |
Do you agree to test an already approved drugs on patients? | Yes No/not sure | 320 160 | 66.7 33.3 |
Do you agree to test a new experimental drug on healthy volunteers? | Yes No/not sure | 256 224 | 53.3 46.7 |
Do you agree to test a new experimental drug on child patients? | Yes No/not sure | 57 423 | 11.9 88.1 |
Do you agree to test an already approved drug on child patients? | Yes No/not sure | 221 259 | 46.0 54.0 |
Are you willing to participate in a CT? | Yes No/not sure | 56 424 | 11.7 88.3 |
Do you want to know more about CT? | Yes No | 359 121 | 74.8 25.2 |
What is your perception towards CT? | Positive answer Negative answer | 309 171 | 64.4 35.6 |
Would you trust the research team which is conducting the CT? | Yes No/not sure | 360 120 | 75.0 25.0 |
Total attitude score | 4.38 ± 2.04 |
Variable | Knowledge | Attitude | ||||||
---|---|---|---|---|---|---|---|---|
Total | Low and Moderate (n = 416) | Excellent (n = 64) | p-Value | Low and Moderate (n = 424) | Excellent (n = 56) | p-Value | ||
Age group (years) | Less than 30 years 30 to 45 years Above 45 years | 190 165 125 | 159 (83.7) 149 (90.3) 108 (86.4) | 31 (16.3) 16 (9.7) 17 (13.6) | 0.187 | 163 (85.8) 149 (90.3) 112 (89.6) | 27 (14.2) 16 (9.7) 13 (10.4) | 0.366 |
Gender | Male Female | 305 175 | 266 (87.2) 150 (85.7) | 39 (12.8) 25 (14.3) | 0.369 | 268 (87.9) 156 (89.1) | 37 (12.1) 19 (10.9) | 0.397 |
Marital status | Married Unmarried | 361 119 | 314 (87.0) 102 (85.7) | 47 (13.0) 17 (14.3) | 0.415 | 326 (90.3) 98 (82.4) | 35 (9.7) 21 (17.6) | 0.019 * |
Employment status | Public sector job Private job/self-employed Unemployed Retired | 195 111 102 72 | 173 (88.7) 92 (82.9) 91 (89.2) 60 (83.3) | 22 (11.3) 19 (17.1) 11 (10.8) 12 (16.7) | 0.512 | 175 (89.7) 100 (90.1) 85 (83.3) 64 (88.9) | 20 (10.3) 11 (9.9) 17 (16.7) 8 (11.1) | 0.461 |
Education level | Up to high school University or higher | 179 301 | 165 (92.2) 251 (83.4) | 14 (7.8) 50 (16.6) | 0.006 * | 158 (88.3) 266 (88.4) | 21 (11.7) 35 (11.6) | 0.973 |
Income ** (monthly) | Less than SAR 5000 SAR 5000 to 10,000 More than SAR 10,000 | 161 172 147 | 137 (85.1) 145 (84.3) 134 (91.2) | 24 (14.9) 27 (15.7) 13 (8.8) | 0.154 | 143 (88.8) 152 (88.4) 129 (87.8) | 18 (11.1) 20 (11.6) 18 (12.2) | 0.958 |
Presence of any chronic diseases | Yes No | 124 356 | 103 (83.1) 313 (87.9) | 21 (16.9) 43 (12.1) | 0.113 | 101 (81.5) 323 (90.7) | 23 (18.5) 33 (9.3) | 0.006 * |
Previous participation in health research | Yes No | 73 407 | 54 (74.0) 362 (88.9) | 19 (26.0) 45 (11.1) | 0.005 * | 60 (82.2) 364 (89.4) | 13 (17.8) 43 (10.6) | 0.206 |
Variables | Knowledge (Poor and Moderate vs. Excellent) | Attitude (Poor and Moderate vs. Excellent) | |||
---|---|---|---|---|---|
Adjusted Odds Ratio (AOR) **/95% Confidence Interval (CI) | p-Value | AOR ** (95% CI) | p-Value | ||
Age group (years) | Less than 30 years 30 to 45 years Above 45 years | Ref. 0.56 (0.29–1.09) 0.79 (0.41–1.54) | 0.088 0.500 | Ref. 0.66 (0.38–1.31) 0.73 (0.35–1.50) | 0.238 0.389 |
Gender | Male Female | Ref. 1.12 (0.63–2.01) | 0.704 | Ref. 1.02 (0.54–1.91) | 0.960 |
Marital status | Married Unmarried | Ref. 1.14 (0.61–2.11) | 0.689 | Ref. 1.84 (1.17–2.98) | 0.035 * |
Employment status | Public sector job Private job/self-employed Unemployed Retired | Ref. 1.24 (0.50–3.06) 0.98 (0.44–2.18) 1.48 (0.58–3.74) | 0.637 0.951 0.411 | Ref. 0.48 (0.19–1.20) 0.54 (0.26–1.15) 0.55 (0.21–1.44) | 0.117 0.111 0.225 |
Education level | Up to high school University or higher | Ref. 1.73 (1.15–2.84) | 0.031 * | Ref. 1.15 (0.60–2.18) | 0.677 |
Income (monthly) | Less than SAR 5000 SAR 5000 to 10,000 More than SAR 10,000 | Ref. 0.62 (0.31–1.19) 1.58 (0.79–2.74) | 0.148 0.728 | Ref. 1.06 (0.57–1.98) 0.91 (0.53–2.11) | 0.854 0.512 |
Presence of any chronic diseases | Yes No | Ref. 0.66 (0.37–1.18) | 0.159 | Ref. 0.71 (0.54–0.91) | 0.008 * |
Previous participation in health research | Yes No | Ref. 0.63 (0.47–0.89) | 0.007 * | Ref. 0.49 (0.23–1.04) | 0.062 |
Spearman’s Coefficient Value (rho) | p-Value | |
---|---|---|
Knowledge–Attitude | 0.329 | <0.001 * |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Abouelkheir, M.; Taha, A.E.; Thirunavukkarasu, A.; Alkhamsan, W.S.S.; Almutairi, F.K.S.; Alanazi, A.A.A.; Alruwaili, A.L.M.; Alriwely, N.S. Knowledge and Attitude towards Clinical Trials among General Population of Northern Saudi Arabia during COVID-19 Era: A Cross-Sectional Study. Healthcare 2023, 11, 680. https://doi.org/10.3390/healthcare11050680
Abouelkheir M, Taha AE, Thirunavukkarasu A, Alkhamsan WSS, Almutairi FKS, Alanazi AAA, Alruwaili ALM, Alriwely NS. Knowledge and Attitude towards Clinical Trials among General Population of Northern Saudi Arabia during COVID-19 Era: A Cross-Sectional Study. Healthcare. 2023; 11(5):680. https://doi.org/10.3390/healthcare11050680
Chicago/Turabian StyleAbouelkheir, Mohamed, Ahmed E. Taha, Ashokkumar Thirunavukkarasu, Wesam Saad S. Alkhamsan, Fahd Khalid S. Almutairi, Ali Awadh A. Alanazi, Abdulaziz Lafi M. Alruwaili, and Nasser Saleh Alriwely. 2023. "Knowledge and Attitude towards Clinical Trials among General Population of Northern Saudi Arabia during COVID-19 Era: A Cross-Sectional Study" Healthcare 11, no. 5: 680. https://doi.org/10.3390/healthcare11050680
APA StyleAbouelkheir, M., Taha, A. E., Thirunavukkarasu, A., Alkhamsan, W. S. S., Almutairi, F. K. S., Alanazi, A. A. A., Alruwaili, A. L. M., & Alriwely, N. S. (2023). Knowledge and Attitude towards Clinical Trials among General Population of Northern Saudi Arabia during COVID-19 Era: A Cross-Sectional Study. Healthcare, 11(5), 680. https://doi.org/10.3390/healthcare11050680